ACAPITAL FERTILITY AND GENOMICS, FI
•CLASE A
Valor Liquidativo
Patrimonio
Cartera Renta Variable
Activo | Div. | Valor | Peso | Dif. |
---|---|---|---|---|
US92532F1003 VERTEX PHARMAC | EUR | 99.547 € | 5.16% | 0.31% |
US2166484020 COOPER COS INC | EUR | 92.672 € | 4.8% | 3.37% |
DK0060534915 NOVO NORDISK A/ | EUR | 85.775 € | 4.45% | 19.16% |
SE0011205202 VITROLIFE AB | EUR | 82.235 € | 4.26% | 17.09% |
US8835561023 THERMO FISHER S | EUR | 81.797 € | 4.24% | 0.79% |
US7140461093 PERKINELMER INC | EUR | 81.346 € | 4.22% | 3.5% |
US0311621009 AMGEN | EUR | 70.171 € | 3.64% | 5.66% |
US00846U1016 AGILENT TECHN. | EUR | 59.835 € | 3.1% | 23.33% |
DE0006599905 MERCK | EUR | 58.250 € | 3.02% | 12.36% |
CA4078911001 HAMILTON THORNE | EUR | 57.886 € | 3% | 5.19% |
US0028241000 ABBOTT LABORATO | EUR | 51.795 € | 2.68% | 1.09% |
US0758871091 BECTON DICKINSO | EUR | 47.038 € | 2.44% | 0.97% |
US74834L1008 QUEST DIAGNOST | EUR | 46.035 € | 2.39% | 15.15% |
US74340E1038 PROGYNY INC | EUR | 45.832 € | 2.38% | 4.95% |
CH0012032113 ROCHE HOLDING | EUR | 44.618 € | 2.31% | 1.64% |
US58933Y1055 MERCK | EUR | 38.453 € | 1.99% | 19.11% |
CH0012032048 ROCHE HOLDING | EUR | 35.283 € | 1.83% | 7.79% |
SE0009778848 MEDICOVER AB B | EUR | 34.556 € | 1.79% | 0.83% |
CH0334081137 CRISPR THERAPEU | EUR | 34.405 € | 1.78% | 34.53% |
AU000000MVF3 MONASH IVF GROU | EUR | 33.865 € | 1.76% | 1.85% |
CNE100003F19 WUXI APPTEC CO | EUR | 33.314 € | 1.73% | 22.03% |
US00287Y1091 ABBVIE INC-WHEN | EUR | 31.403 € | 1.63% | 3.28% |
KYG5140J1013 JINXIN FERTILIT | EUR | 28.226 € | 1.46% | 1.46% |
CNE100000FN7 SINOPHARM GROUP | EUR | 26.004 € | 1.35% | 3.08% |
US75886F1075 REGENERON PHARM | EUR | 22.916 € | 1.19% | 19.47% |
US88025U1097 10X GENOMICS CL | EUR | 23.046 € | 1.19% | 21.18% |
US1255231003 CIGNA | EUR | 15.167 € | 0.79% | 23.07% |
US50540R4092 LABORATORY CORP | EUR | 15.179 € | 0.79% | 1.65% |
US28106W1036 EDITAS MEDICINE | EUR | 12.222 € | 0.63% | 26.61% |
US45826J1051 INTELLIA THER | EUR | 12.223 € | 0.63% | 34.02% |
US3755581036 GILEAD SCIENCES | EUR | 12.030 € | 0.62% | 35.95% |
US69404D1081 PACIFIC BIOSCIE | EUR | 11.913 € | 0.62% | 81.13% |
US4523271090 ILLUMINA INC | EUR | 10.956 € | 0.57% | 7.35% |
US0905722072 BIO RAD LABORAT | EUR | 9428 € | 0.49% | 16.85% |
ES0171996087 GRIFOLS | EUR | 8648 € | 0.45% | 40.28% |
US1101221083 BRISTOL-MYE. S. | EUR | 5982 € | 0.31% | 8.55% |
US90184D1000 TWIST BIOSCIENC | EUR | 5183 € | 0.27% | 33.33% |
US60770K1079 MODERNA INC | EUR | 4027 € | 0.21% | 23.07% |
US6323071042 NATERA | EUR | 3227 € | 0.17% | 75.28% |
US0547548745 AYTU BIOSCIENCE | EUR | 252 € | 0.01% | 73.25% |
US29082K1051 EMBECTA CORP | EUR | 213 € | 0.01% | 2.29% |
US09062X1037 BIOGEN | EUR | 0 € | 0% | Vendida |
Cartera ICC
Activo | Div. | Valor | Peso | Dif. |
---|---|---|---|---|
US46138G5999 INVESCO NASDAQ | EUR | 96.002 € | 4.98% | 9.63% |
US00214Q3020 ARK GENOMIC REV | EUR | 73.842 € | 3.83% | 12.25% |
US46435U1925 ISHARES GENOMIC | EUR | 7054 € | 0.37% | 14.76% |
2022-Q4
Renta Variable Internacional
EUR
129.427,49
141
0
1.699.452 €
13,13 €
Política de Inversión
Operativa con derivadosLa metodología aplicada para calcular la exposición total al riesgo es la metodología del compromiso. Una información más detallada sobre la política de inversión del fondo se puede encontrar en su folleto informativo.
Sectores
- Salud
99.98%
- No Clasificado
0.02%
Regiones
- Estados Unidos
61.77%
- Europa
26.05%
- China
5.94%
- Canada
3.93%
- Australia
2.30%
Tipo de Inversión
- Large Cap - Blend
25.29%
- Large Cap - Growth
24.46%
- Medium Cap - Blend
13.20%
- Small Cap - Growth
9.23%
- Medium Cap - Growth
8.09%
- Small Cap - Blend
7.06%
- Medium Cap - Value
6.49%
- Large Cap - Value
6.15%
- Small Cap - Value
0.01%
- No Clasificado
0.02%
Comisiones
Comisión de gestión
Total2.00
1.01
Comisión de depositario
Total0.09
0.05